Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Exploratory Clinical Study of KUX-1151

Trial Profile

Phase II Exploratory Clinical Study of KUX-1151

Phase of Trial: Phase II

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs KUX 1151 (Primary)
  • Indications Gout; Hyperuricaemia
  • Focus Therapeutic Use
  • Sponsors Kissei Pharmaceutical
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 16 Oct 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 19 Apr 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top